Heart Surgery news on Thursday, November 19, 2026
In Heart Surgery on Thursday, November 19, 2026: New Drug Hopes to Cut Delirium After Heart Surgery. Also: EA-230 drug enrolls first Phase III patient for post-cardiac surgery recovery acceleration; Correcting anemia before cardiac surgery shows measurable value and positive clinical impact.
Get it by email every morning, free
Headlines
- Esketamine may reduce delirium risk after adult cardiac surgery in clinical research.Bioengineer.org
- EA-230 drug enrolls first Phase III patient for post-cardiac surgery recovery acceleration.Tech Times
- Correcting anemia before cardiac surgery shows measurable value and positive clinical impact.Open Access Government
- Internal mammary artery harvesting linked to higher risk of phrenic nerve dysfunction.Bioengineer.org
- Communication failures in cardiac surgery teams significantly increase complication risks and costs.Medical Dialogues
4 more in this edition
Free for subscribers: the whole list every morning and the complete daily archive.
← November 18, 2026Heart Surgery news todayNovember 20, 2026 →
Earlier editions
Every line is our own one-sentence summary and links to the original publisher. Sources: public news found through Google News and Bing News, moderated posts from readers, weather from MET Norway (CC BY 4.0).